Home » Authors » Mark McCarty

Articles by Mark McCarty

Structural costs, inefficiencies counter opportunities in Japan

Nov. 2, 2006

By Mark McCarty

Big wave of ‘nano’ products will test readiness of FDA

Nov. 1, 2006

By Mark McCarty

Adverse cardio event reporting guidelines rolled out by HRS

Nov. 1, 2006

By Mark McCarty

Alternative materials offer surprising new options vs. stenting

Nov. 1, 2006

By Mark McCarty

China s reforms still clearly murky for healthcare sector

Nov. 1, 2006

By Mark McCarty

Management experience said to be key for device start-ups

Oct. 27, 2006

By Mark McCarty

C-reactive protein moves down, calcium up as CHD predictors

Oct. 26, 2006

By Mark McCarty

Cineangiography radiation dose a peril for docs and patients

Oct. 26, 2006

By Mark McCarty

Beefed-up CT, MR technologies moving in on X-ray angiography

Oct. 26, 2006

By Mark McCarty

Researchers pushing stem cell, gene therapies for cardiac use

Oct. 26, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...